Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.96 |
| ▸ | GAA | P10253 | 5/20 | 0.83 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 5/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | HTT | P42858 | 3/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | NSD2 | O96028 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | MPI | P34949 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etocarlide SCHEMBL103618 | 0.98 | MAPT (1.00) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL9263 | 0.98 | MAPT (1.00) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL3459278 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL938885 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL29187 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL120610 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL20994029 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL20658914 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL20447982 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL1654904 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3835329-B1 | POLYMERIZATION INITIATOR, CURABLE COMPOSITION, DENTAL MATERIAL, AND PREPARATION KIT FOR CURABLE COMPOSITION | MITSUI CHEMICALS INC (JP) | 2024-05-01 | — | — | EP | disclosed |
| US-20230323084-A1 | POLYMERIZATION INITIATOR, CURABLE COMPOSITION, DENTAL MATERIAL, AND PREPARATION KIT FOR CURABLE COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-11744782-B2 | Separately packed curable composition | MITSUI CHEMICALS, INC. (JP) | 2023-09-05 | — | — | US | disclosed |
| US-11306160-B2 | Curable composition | MITSUI CHEMICALS, INC. (JP) | 2022-04-19 | — | — | US | disclosed |
| EP-3835329-A1 | POLYMERIZATION INITIATOR, CURABLE COMPOSITION, DENTAL MATERIAL, AND PREPARATION KIT FOR CURABLE COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2021-06-16 | — | — | EP | disclosed |
| US-20210169749-A1 | SEPARATELY PACKED CURABLE COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2021-06-10 | — | — | US | disclosed |
| US-20210130580-A1 | POLYMERIZATION INITIATOR, CURABLE COMPOSITION, DENTAL MATERIAL, AND PREPARATION KIT FOR CURABLE COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2021-05-06 | — | — | US | disclosed |
| US-20200291157-A1 | CURABLE COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2020-09-17 | — | — | US | disclosed |
| EP-3702377-A1 | CURABLE COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2020-09-02 | — | — | EP | disclosed |
| EP-3666247-A1 | DIVIDED CURABLE COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2020-06-17 | — | — | EP | disclosed |
| WO-2020031897-A1 | POLYMERIZATION INITIATOR, CURABLE COMPOSITION, DENTAL MATERIAL, AND PREPARATION KIT FOR CURABLE COMPOSITION | 三井化学株式会社 | 2020-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11306160-B2 | Curable composition | COIL, CLPX, CBX7 | MAPT 110/4885GAA 1055/4885L3MBTL1 3679/4885 |
| US-20200291157-A1 | CURABLE COMPOSITION | COIL, CLPX, CBX7 | MAPT 110/4885GAA 1055/4885L3MBTL1 3679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.